Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals
Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma
Natasha LeGresley (@tashlegr) / Twitter
Ioannis Gounaris's research works | Novartis, Basel and other places
Ovarian clear cell carcinoma—bad endometriosis or bad endometrium? - Gounaris - 2011 - The Journal of Pathology - Wiley Online Library
Trabectedin for advanced soft tissue sarcomas: a single institution experience | Future Oncology
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals
Ioannis Gounaris's research works | Novartis, Basel and other places
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study. - Abstract - Europe PMC
Ioannis Gounaris's research works | Novartis, Basel and other places
Our Publications
Application of ARID1A to murine formalin-fixed... | F1000Research
Cambridge City Council on Twitter: "Cambridge market will reopen on Monday (18 January) with traders selling fresh food and produce, plants and cycle services. Full details: https://t.co/A7FZJIn6ki #StaySafeCambridge https://t.co/oeDAb869qx" / Twitter
Simple blood test could quickly predict how ovarian cancer patients are likely to respond to chemotherapy treatment | Obs Gynae & Midwifery News – Incorporating Women's Health
Ioannis Gounaris - Executive Medical Director - Merck Group | LinkedIn
Ioannis Gounaris's research works | Novartis, Basel and other places
7 perfiles de «Ioannis Gounaris» | LinkedIn
A Bumpy Virtual #ASCO20; Returning to Chicago in 2021?
Trabectedin for advanced soft tissue sarcomas: a single institution experience | Future Oncology
Ioannis Gounaris's research works | Novartis, Basel and other places
Ioannis Gounaris's research works | Novartis, Basel and other places
CRUK Cambridge Institute ar Twitter: "A huge congratulations to Dr Oscar Rueda on his new position at the @MRC_BSU @Cambridge_Uni! Oscar has been in our @CaldasLab working on the Personalised Breast Cancer
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals
